Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19
Severe/critical cases account for 18%–20% of all COVID-19 patients, but their mortality rate can be up to 61.5%. Furthermore, all deceased patients were severe/critical cases. The main reasons for the high mortality of severe/critical patients are advanced age (>60 years old) and combined underly...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12230
- Acceso en línea:
- https://doi.org/10.1016/j.livres.2020.08.001
http://hdl.handle.net/20.500.12010/12230
- Palabra clave:
- SARS-CoV-2 novel coronavirus disease 2019 (COVID-19)
Severe COVID-19
Critical COVID-19
Treatment
Plan
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)